Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
12 participants
OBSERVATIONAL
2016-10-31
2018-03-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
The main objective is to confirm feasibilty and safety of patient-specific implants for one or multi-level corpectomy and fusion.
This study was approved in March 2016 allowing to include retrospectivley all patients since the first implantation in January 2015 and prospectively all patients after the approval.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
UNiD Rods Register
NCT02926404
Cervical Arthroplasty "Fixed Core" Versus "Movable Core": Clinical and Radiological Impact in the Medium Term
NCT02924506
A Prospective Study of the Safety and Efficacy of 3D-printed Non-rigid Biomimetic Implant in Cervical and Thoracolumbar Spine
NCT05396222
Re-operation Rates of Concorde Bullet Device Versus Conduit Titanium Interbody Graft for Lumbar Fusion
NCT05993195
Safety and Preliminary Effectiveness of NVD-001 for the Treatment of Low Grade Degenerative Lumbar Spondylolisthesis
NCT03100032
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
COHORT
PROSPECTIVE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Cervical
30 patients who need anterior cervical corpectomy and fusion with patient-specific implants (UNiD 3D VBR)
UNiD 3D VBR
Corpectomy of one or several vertebral body(ies) followed by vertebral body(ies) replacement and fusion
Thoraco-lumbar
30 patients who need anterior thoracolumbar corpectomy and fusion with patient-specific implants (UNiD 3D VBR)
UNiD 3D VBR
Corpectomy of one or several vertebral body(ies) followed by vertebral body(ies) replacement and fusion
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
UNiD 3D VBR
Corpectomy of one or several vertebral body(ies) followed by vertebral body(ies) replacement and fusion
Other Intervention Names
Discover alternative or legacy names that may be used to describe the listed interventions across different sources.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Cervical region
* Fracture / Trauma
* Tumors
* Cervical spondylotic myelopathy
* Infection (Ex: Osteomyelitis)
* Spinal instability
* Symptomatic degenerative spinal disease
* Inflammatory rheumatism.
* Pseudarthrosis
* Thoracolumbar region
* Fracture / Trauma
* Tumors
* Infection (Ex: Osteomyelitis)
* Spinal instability
* Symptomatic degenerative spinal disease
* Pseudarthrosis
2. Patients \> 18 years
3. Patients who signed an Informed Consent Form
Exclusion Criteria
2. Patients unable to fill HRQOL questionnaires
3. Non-compliant paitents regarding follow-up or protocol
4. Pregnant patient or intended to be pregnant within the next 2 years
5. Sytemic or local infection
6. Allergy known or suspected to a componant
7. Patients presenting a contraindication as indicated in the instruction for use
18 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Medicrea International
INDUSTRY
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Jean-Edouard Loret, MD
Role: PRINCIPAL_INVESTIGATOR
CHU Tours
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
CHU Tours
Tours, , France
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
1801
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.